It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Peripheral vascular diseases (PVDs) represent a significant burden on global human health and healthcare systems. With continued growth in obesity and diabetes, it is likely that the incidence of these conditions will increase. As many PVDs remain undiagnosed, low-cost and easy to use diagnostic methods are required. This work uses newly developed wearable electro-resistive morphic sensors to assess venous and arterial competence in the lower limbs of 36 healthy subjects. Comparison of this HeMo device was made to currently available benchtop light reflection rheography and photoplethymography devices. Results indicate that HeMo can detect the physiological signals of interest for both chronic venous insufficiency and peripheral arterial disease and all subjects were interpreted as healthy by each system. However, measurement repeatability of HeMo was highlighted as an issue that requires further system development. Furthermore, as HeMo captures changes in a section of limb circumference due to changes in underlying blood movement, rather than at a single point, the recorded signal is typically damped by comparison. This factor should be considered in any future developments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Western Sydney University, The MARCS Institute for Brain, Behaviour and Development, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719)
2 Western Sydney University, The MARCS Institute for Brain, Behaviour and Development, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719); Western Sydney University, School of Engineering, Design and Built Environment, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719)
3 South Western Sydney Local Health District, South Western Sydney Limb Preservation and Wound Research, Liverpool Hospital, Liverpool, Australia (GRID:grid.410692.8) (ISNI:0000 0001 2105 7653); Western Sydney University, Infectious Diseases and Microbiology, School of Medicine, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719)
4 Western Sydney University, The MARCS Institute for Brain, Behaviour and Development, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719); Western Sydney University, Translational Health Research Institute, Sydney, Australia (GRID:grid.1029.a) (ISNI:0000 0000 9939 5719)